Abstract
Introduction

47
Diabetic nephropathy (DN), a complicated microvascular disease associated with 48 diabetes mellitus (DM), is a significant cause of chronic kidney disease (CKD) [1] . In a type 49 1 diabetes mellitus (T1DM) population with a mean age of 44 years and duration of diabetes 50 of 17 years, up to 21.0% of patients developed CKD [2] . Similarly, DN occurs in 20% to 51 40% of all cases of type 2 diabetes mellitus (T2DM) [3] . Approximately 14.5% mortality was The prevention of activated renin-angiotensin-aldosterone system (RAAS) in diabetic 57 kidney has a vital role in treatment of DN [7] . Drugs that block RASS pathway are effective 58 in reducing nephropathy progression in diabetic patients and delaying cardiovascular and 59 renal morbidity and mortality [8] . factor-α (TNF-α), caspase-3, B cell lymphoma-2 (Bcl-2), and protein 53 (P53) genes.
83
Materials and Methods
84
Experimental Animals
85
Male albino rats of Wistar strain weighing about 100-130 grams were used in this study.
86
After two weeks of adaptation period, the animals were housed in clean polypropylene cages and Ahmed [22] respectively.
151
Statistical analysis
152
The data were analysed using the one-way analysis of variance (ANOVA) (PC-STAT, 
Results
157
Serum urea, uric acid and creatinine levels were significantly (p<0.01; LSD) elevated in 158 diabetic control group while this elevation was remarkably decreased in diabetic treated 159 groups with F-probabilities P<0.001, P<0.05 and P<0.01 respectively ( Table 1 ). The 
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On the other hand, the elevated fasting and postprandial blood glucose levels in diabetic 
225
Histopathological examination of kidney tissues of diabetic group showed severe 226 necrosis of epithelial cells lining renal tubules, intense congestion of glomerular tuft (Fig 1;   227 Photomicrograph B) and intertubular hemorrhage as compared with kidney histological 228 structure of normal group (Fig 1; Photomicrograph A) . The kidney section of diabetic group 229 treated with enalapril showed no histopathological changes (Fig 1; Photomicrograph C size of islets and necrotic changes in the islet cells and subsequent kidney dysfunction.
306
In the present study, the STZ-induced diabetic rats exhibited impairment in kidney 307 function that was manifested by a significant elevation of serum urea, uric acid, creatinine 
336
The treatment of diabetic rats with enalapril and/or paricalcitol, in the present study, including RAAS, the nuclear factor-κB (NF-κB), the transforming growth factor-β (TGF-361 β)/Smad, and the Wnt/β-catenin signaling pathways [37, 38, 39] .
362
The increased LPO in the renal tissue observed in diabetic rats, in present study, was 
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The present results are also in consistence with a previous study of the effect of paricalcitol in 
418
The p53 protein together with these pro-apoptotic proteins, are moved into the mitochondria 419 where they encourage an upsurge in the permeability of mitochondrial membranes and the 420 release of cytochrome C, which attaches to the apoptotic protease activating factor 1 (Apaf-1) 
429
The antiapoptotic effect of enalapril observed in the current study was also in accordance 
440
Conclusions
441
The study concluded that paricalcitol and/or enalapril potentially protect against STZ- 
